2005년 2월 15일 화요일 재생 중

2005년 2월 15일은(는) 화요일의 별 기호 아래에 있는 **♒**입니다. 올해의 45일이었습니다. 미국 대통령은 George W. Bush입니다.

이 날에 태어났다면 당신은 21살입니다. 마지막 생일은 2026년 2월 15일 일요일, 111일 전이었습니다. 다음 생일은 2027년 2월 15일 월요일일 후 253입니다. 당신은 7,781일, 약 186,765시간, 약 11,205,955분 또는 약 672,357,300초 동안 살았습니다.

이 생일을 공유하는 사람들:

15th of February 2005 News

2005년 2월 15일 의 New York Times 1면에 실린 뉴스

COMPENSATION CUT FOR SOME ON CONTINENTAL'S BOARD

Date: 16 February 2005

By Bloomberg News

Bloomberg News

Continental Airlines says its board agreed to reduce fees for most directors by 30 percent and to forgo stock-option grants this year to help cut labor costs; reductions begin Feb 28 and affect annual retainer, which was $35,000 last year, as well as meeting fees, which were as much as $2,000 per meeting for directors who are not company employees (S)

Full Article

ENCYSIVE REPORTS RESULTS FOR A PULMONARY DRUG

Date: 15 February 2005

By Bloomberg News

Bloomberg News

Encysive Pharmaceuticals Inc., a biotechnology company based in Houston, said yesterday that a study showed its Thelin drug improved exercise tolerance in people with a condition that damages the lungs and heart. People taking Thelin for pulmonary arterial hypertension added about 26.5 yards to the distance they could walk in six minutes during the 18-week test, while those on a placebo worsened, the company said. Encysive said it intended to file in April for Food and Drug Administration clearance to sell Thelin, which would be a competitor to Tracleer from Actelion Ltd., which was included in the study. Thelin showed a lower rate of side effects than Tracleer, Encysive said. Stock in Encysive rose $1.29, to $11.80 a share.

Full Article

F.D.A. WILL APPROVE DRUG FROM DISCOVERY LABORATORIES

Date: 15 February 2005

By Bloomberg News

Bloomberg News

Discovery Laboratories Inc. said yesterday that the Food and Drug Administration said it would approve the company's Surfaxin respiratory drug for premature infants. The F.D.A. will approve Surfaxin after Discovery completes labeling and corrects issues with manufacturing practices, the company said. The company's manufacturer, Laureate Pharma Inc., is bringing the sterility of its production environment to levels required by the F.D.A., and is changing some paperwork, Discovery's chief executive, Robert J. Capetola, said. Surfaxin mimics a human lung protein that helps the lung absorb oxygen, he said.

Full Article

MAJOR LEAGUE BASEBALL UNIT PURCHASING TICKETS.COM

Date: 16 February 2005

By Bloomberg News

Bloomberg News

MLB Advanced Media unit of Major League Baseball agrees to buy Tickets.com, online seller of sporting events and concert tickets, for about $66.5 million (S)

Full Article

MACQUARIE AND REGENCY TO BUY 101 SHOPPING CENTERS

Date: 16 February 2005

By Bloomberg News

Bloomberg News

Macquarie CountryWide Trust of Australia and Regency Centers Corp acquire 101 shopping centers from California Public Employees' Retirement System for about $2.74 billion; Macquarie will own 65 percent of venture (S)

Full Article

Technology Briefing | Hardware: Network Appliance Posts Income Increase

Date: 16 February 2005

By Bloomberg News

Bloomberg News

Network Appliance says fiscal third-quarter net income rose 50 percent, to $60.1 million, on sales of $412.7 million (S)

Full Article

E*Trade Cuts Some Fees

Date: 16 February 2005

By Bloomberg News

Bloomberg News

E*Trade Financial Corp cuts trading commissions (S)

Full Article

National Briefing | Science and Health: Study Favors Young Doctors

Date: 16 February 2005

By Bloomberg News

Bloomberg News

Harvard Medical School study finds that older doctors are less likely to stay current on recommended methods of patient care (S)

Full Article

World Business Briefing | Americas: Canada: Loss At Communications Concern

Date: 16 February 2005

By Bloomberg News

Bloomberg News

Rogers Communications says net loss was 15.5 million Canadian dollars ($12.5 million) in fourth quarter compared with net income of 68.8 million Canadian dollars year earlier; revenue rose 21 percent, to 1.57 billion Canadian dollars ($1.3 billion) (S)

Full Article

World Business Briefing | Australia: Australia: Slot Machine Maker In Talks

Date: 16 February 2005

By Bloomberg News

Bloomberg News

Unicum, owned by Boris Belotserkovsky, owner of biggest casino and gaming equipment distributor in Russia, may buy majority stake in Ainsworth Game Technology of Australia to gain control of his supplier of slot machines; proposed bid for stake has market value of $138 million (S)

Full Article